anti-Her-2-CAR retroviral vector-transduced autologous peripheral blood lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-010762
Autologous human peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding an anti-Her-2 (epidermal growth factor receptor 2) chimeric T cell receptor (chimeric antigen receptor or CAR) gene with potential immunostimulatory and antineoplastic activities. Autologous PBLs from a patient with Her-2-positive cancer are pulsed with a retroviral vector that encodes the CAR gene specific for Her-2. After expansion in culture and reintroduction into the patient, anti-Her-2-CAR retroviral vector-transduced autologous peripheral blood lymphocytes, expressing anti-Her-2-CAR on their cell surfaces, bind to Her-2 antigen on tumor cell surfaces; subsequently, Her-2-expressing tumor cells may be lysed. Her-2 (ErbB-2), a receptor tyrosine kinase (RTK) overexpressed by a variety of cancer cell types, belongs to the EGFR superfamily and plays key roles in tumor cell proliferation and tumor angiogenesis.
| Identifier | MLC-T-ONC-010762 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-Her-2-chimeric antigen receptor-engineered autologous peripheral blood lymphocytes; anti-Her-2-CAR-engineered autologous PBLs; anti-Her-2-CAR-engineered autologous peripheral blood lymphocytes |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010762",
"term": "anti-Her-2-CAR retroviral vector-transduced autologous peripheral blood lymphocytes",
"field": "Oncology and biomedicine",
"definition": "Autologous human peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding an anti-Her-2 (epidermal growth factor receptor 2) chimeric T cell receptor (chimeric antigen receptor or CAR) gene with potential immunostimulatory and antineoplastic activities. Autologous PBLs from a patient with Her-2-positive cancer are pulsed with a retroviral vector that encodes the CAR gene specific for Her-2. After expansion in culture and reintroduction into the patient, anti-Her-2-CAR retroviral vector-transduced autologous peripheral blood lymphocytes, expressing anti-Her-2-CAR on their cell surfaces, bind to Her-2 antigen on tumor cell surfaces; subsequently, Her-2-expressing tumor cells may be lysed. Her-2 (ErbB-2), a receptor tyrosine kinase (RTK) overexpressed by a variety of cancer cell types, belongs to the EGFR superfamily and plays key roles in tumor cell proliferation and tumor angiogenesis.",
"synonyms": [
"anti-Her-2-chimeric antigen receptor-engineered autologous peripheral blood lymphocytes",
"anti-Her-2-CAR-engineered autologous PBLs",
"anti-Her-2-CAR-engineered autologous peripheral blood lymphocytes"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-her-2-car-retroviral-vector-transduced-autologous-peripheral-blood/"
}
Record 1,870 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.